Holen Sie sich die Stockscreener-App
14.70
0.07%
-0.01
Handel nachbörslich:
14.70
Finanzdaten der Edgewise Therapeutics Inc-Aktie (EWTX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
7.29%
42.61
|
45.96 | 40.43 | 38.11 | 34.75 |
| Operating Income/Loss |
7.29%
-42.61
|
-45.96 | -40.43 | -38.11 | -34.75 |
| Income/Loss From Continuing Operations Before Tax |
11.48%
-36.12
|
-40.80 | -34.13 | -31.50 | -28.52 |
| Income/Loss From Continuing Operations After Tax |
11.48%
-36.12
|
-40.80 | -34.13 | -31.50 | -28.52 |
|
Net Income/Loss
|
11.48%
-36.12
|
-40.80 | -34.13 | -31.50 | -28.52 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
10.31%
104.94
|
95.13 | 93.81 | 93.52 | 87.57 |
| Diluted Average Shares |
10.31%
104.94
|
95.13 | 93.81 | 93.52 | 87.57 |
| Basic Earnings Per Share |
20.93%
-0.34
|
-0.43 | -0.36 | -0.34 | -0.33 |
| Diluted Earnings Per Share |
20.93%
-0.34
|
-0.43 | -0.36 | -0.34 | -0.33 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
5.15%
1.45%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):